pillbase.ru

Xiidra

Active substance: lifitegrast

Lifitegrast

Centralised EU authorisationActive

Marketing holder: Novartis Europharm Limited

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 3
  • Lifitegrast
    FOR SOLUTION · LIFITEGRAST 50 mg/mL
    59651-450
    Aurobindo Pharma Limited
  • Xiidra
    SOLUTION/ DROPS · LIFITEGRAST 50 mg/mL
    24208-911
    Bausch & Lomb Incorporated
  • Xiidra
    SOLUTION/ DROPS · LIFITEGRAST 50 mg/mL
    0078-0911
    Novartis Pharmaceuticals Corporation
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208d-5236-7c52-8725-25837c5c7cc9,01a1208e-0ffb-7dca-8399-4c05a4d6a3d6,01a1208f-8c44-7dd2-a641-e9a2322f5f23;count=3 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/004653
Registration status
Active
ATC code
S01XA25
Sources
  • product · EMA · EMEA/H/C/004653 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/004653 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/004653 · Verified 2026-10-09